CytomX Therapeutics, Inc. (FRA:6C1)
Germany · Delayed Price · Currency is EUR 4.876
+0.470 (10.67%)
Last updated: Jan 28, 2026, 8:02 AM CET
515.66% (1Y)
| Market Cap | 811.47M +1,143.5% |
| Revenue (ttm) | 96.85M -10.3% |
| Net Income | 23.88M +102.6% |
| EPS | 0.20 +50.2% |
| Shares Out | n/a |
| PE Ratio | 33.98 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 118 |
| Open | 4.876 |
| Previous Close | 4.406 |
| Day's Range | 4.876 - 4.876 |
| 52-Week Range | 0.384 - 4.876 |
| Beta | n/a |
| RSI | 62.74 |
| Earnings Date | Mar 6, 2026 |